Molecular ultrasound imaging with vascular endothelial growth factor receptor 2-targeted microbubbles in a mouse liver cancer model

Yang TANG,Wentao KONG,Xiaolong ZHANG,Wenping WANG

DOI: https://doi.org/10.3969/j.issn.1008-617X.2016.04.007

2016-01-01

Abstract:Objective:To evaluate the feasibility and reproducibility of molecular ultrasound imaging of tumor angiogenesis with vascular endothelial growth factor receptor 2 (VEGFR2)-targeted microbubbles.Methods:VEGFR2-targeted microbubbles were accomplished by anti-VEGFR2 monoclonal antibody conjugation to the microbubble surface using biotin-avidin linkage, which was assessedex vivo using immunolfuorescence. Ten mice bearing subcutaneous human liver tumor were divided into two groups randomly (targeted group,n=5; non-targeted group,n=5) and scanned at 2 weeks after implantation with contrast-enhanced ultrasound (CEUS) using either targeted or non-targeted microbubbles. Following CEUS, time-intensity curves were constructed off-line and perfusion parameters were calculated. The residual bubble signal was determined 5 min after contrast agent injection with destruction-replenishment analysis.Results:Both targeted and non-targeted microbubbles revealed signiifcant enhancementin vivo. A signiifcant difference in area under the curve (AUC) was recorded between targeted group and non-targeted group [(3 940.4±200.9) dB?svs. (2 796.8±452.3) dB?s,P=0.001]. After the destruction sequence, there was a signiifcant difference in the decrease of video intensity between targeted group and non-targeted group [(7.61±2.20) dBvs. (3.74±1.40) dB,P=0.010].Conclusion:Molecular ultrasound imaging with VEGFR2-targeted microbubbles is noninvasive, feasible and reproducible to assess tumor angiogenesis.